CD19 and non-Hodgkin lymphoma: A recent clinical study focused on treating CD19+ non-Hodgkin’s lymphoma and chronic lymphocytic leukemia through the infusion of retrovirus-transduced anti-CD19 CAR cord blood NK cells.